Castle Biosciences Secures $11,700,000 Series F Round

  • Feed Type
  • Date
    7/27/2015
  • Company Name
    Castle Biosciences
  • Mailing Address
    2014 San Miguel Dr. Friendswood, TX 77546 USA
  • Company Description
    Castle Biosciences develops and commercializes diagnostic and prognostic tests for cancers that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.
  • Website
    http://www.castlebiosciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,700,000
  • Transaction Round
    Series F
  • Proceeds Purposes
    The funding will be used to accelerate the growth in clinical adoption of the Company’s gene test for identifying metastatic risk in early stage cutaneous melanoma, DecisionDx-Melanoma, and its other tests designed to improve cancer care.
  • M&A Terms
  • Venture Investor
    Industry Ventures
  • Venture Investor
    HealthQuest Capital
  • Venture Investor
    Mountain Group Capital

Trending on Xconomy